Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florence Lerebours

Showing results (11-20 of 100) with videos related to

Pageof 10
Sort By:
Analytical Cellular Pathology (Amsterdam)|May 8, 2020
Altered Expression of Three EGFR Posttranslational Regulators MDGI, MIG6, and EIG121 in Invasive Breast CarcinomasDidier Meseure, Kinan Drak Alsibai, Sophie Vacher, et al.
Plos One|July 28, 2015
Impact of Adjuvant Chemotherapy on Breast Cancer Survival: A Real-World PopulationLea Rossi, Denise Stevens, Jean-Yves Pierga, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 30, 2020
Early metabolic response of breast cancer to neoadjuvant endocrine therapy: comparison to morphological and pathological responseSarah Boughdad, Laurence Champion, Veronique Becette, et al.
Bulletin Du Cancer|March 31, 2015
[Satisfaction of Breast Cancer patients treated by chemotherapy outpatient clinics: Results of the TemporELLES survey]Florence Lerebours, Pierre Saltel, Anne Béthune-Volters, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 4, 2013
¹⁸F-FDG PET/CT imaging versus dynamic contrast-enhanced CT for staging and prognosis of inflammatory breast cancerLaurence Champion, Florence Lerebours, Pascal Cherel, et al.
Breast Cancer Research : BCR|August 9, 2018
Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancerXu Liang, Sophie Vacher, Anais Boulai, et al.
Oncogene|September 15, 2019
ERBB3 mutations in cancer: biological aspects, prevalence and therapeuticsNicolas Kiavue, Luc Cabel, Samia Melaabi, et al.
International Journal of Cancer|November 26, 2002
Evidence of chromosome regions and gene involvement in inflammatory breast cancerFlorence Lerebours, Philippe Bertheau, Ivan Bieche, et al.
Journal of Neuro-Oncology|July 8, 2011
Brain metastases from breast cancer: proposition of new prognostic score including molecular subtypes and treatmentRomuald Le Scodan, Christophe Massard, Ludivine Jouanneau, et al.
Oncotarget|November 12, 2016
Combination of COX-2 expression and PIK3CA mutation as prognostic and predictive markers for celecoxib treatment in breast cancerSandrine Tury, Véronique Becette, Franck Assayag, et al.
Pageof 10

Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
Analytical Cellular Pathology (Amsterdam)|May 8, 2020
Altered Expression of Three EGFR Posttranslational Regulators MDGI, MIG6, and EIG121 in Invasive Breast CarcinomasDidier Meseure, Kinan Drak Alsibai, Sophie Vacher, et al.
Plos One|July 28, 2015
Impact of Adjuvant Chemotherapy on Breast Cancer Survival: A Real-World PopulationLea Rossi, Denise Stevens, Jean-Yves Pierga, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 30, 2020
Early metabolic response of breast cancer to neoadjuvant endocrine therapy: comparison to morphological and pathological responseSarah Boughdad, Laurence Champion, Veronique Becette, et al.
Bulletin Du Cancer|March 31, 2015
[Satisfaction of Breast Cancer patients treated by chemotherapy outpatient clinics: Results of the TemporELLES survey]Florence Lerebours, Pierre Saltel, Anne Béthune-Volters, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 4, 2013
¹⁸F-FDG PET/CT imaging versus dynamic contrast-enhanced CT for staging and prognosis of inflammatory breast cancerLaurence Champion, Florence Lerebours, Pascal Cherel, et al.
Breast Cancer Research : BCR|August 9, 2018
Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancerXu Liang, Sophie Vacher, Anais Boulai, et al.
Oncogene|September 15, 2019
ERBB3 mutations in cancer: biological aspects, prevalence and therapeuticsNicolas Kiavue, Luc Cabel, Samia Melaabi, et al.
International Journal of Cancer|November 26, 2002
Evidence of chromosome regions and gene involvement in inflammatory breast cancerFlorence Lerebours, Philippe Bertheau, Ivan Bieche, et al.
Journal of Neuro-Oncology|July 8, 2011
Brain metastases from breast cancer: proposition of new prognostic score including molecular subtypes and treatmentRomuald Le Scodan, Christophe Massard, Ludivine Jouanneau, et al.
Oncotarget|November 12, 2016
Combination of COX-2 expression and PIK3CA mutation as prognostic and predictive markers for celecoxib treatment in breast cancerSandrine Tury, Véronique Becette, Franck Assayag, et al.
Pageof 10